Some things you just can’t make up.
No, this isn’t an April Fool’s story to be published on Deadspin, nor was it a skit on Saturday Night Live. Sammy Sosa has invested in a company called “Injex 21,” and its primary product is needleless drug injection. To top it off, the press release announcing Sosa’s involvement was distributed the day after the Hall of Fame ballot results were made public.
Read all about it here.
About the Author
Joe Janish began MetsToday in 2005 to provide the unique perspective of a high-level player and coach -- he earned NCAA D-1 All-American honors as a catcher and coached several players who went on to play pro ball. As a result his posts often include mechanical evaluations, scout-like analysis, and opinions that go beyond the numbers. Follow Joe's baseball tips on Twitter at @onbaseball and at the On Baseball Google Plus page.